other material
confidence high
sentiment positive
materiality 0.65
Astrana Health issues FY2024 revenue $1.65-1.85B, Adj. EBITDA $165-185M
Astrana Health, Inc.
- FY2023 rev $1.39B, Adj. EBITDA $146.6M, diluted EPS $1.29.
- FY2024 guidance: rev $1.65-1.85B, Adj. EBITDA $165-185M, EPS $1.28-1.52.
- Closed CFC acquisition Jan 31, 2024; $202M total (cash $152M, equity $20M, milestones $30M).
- 10,000+ providers, ~900k VBC members; 48% fewer hospital admits vs benchmark.
- Care Enablement segment long-term EBITDA margin target 20-30%.